--- a
+++ b/clusters/9knumclustersv2/clust_1070.txt
@@ -0,0 +1,160 @@
+Patients with known human immunodeficiency virus (HIV) or hepatitis B or C are excluded
+Previously known infection with human immunodeficiency virus (HIV); or hepatitis B or hepatitis C infection.
+History of human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
+Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C.
+Known history of human immunodeficiency virus infection (HIV) or hepatitis C or active hepatitis B infection, unless the patient was diagnosed > years prior to enrollment and no evidence of active liver disease.
+EXCLUSION CRITERIA FOR SECOND-LINE THERAPY: Active severe infection, or known chronic infection with human immunodeficiency virus (HIV) or hepatitis B virus
+EXCLUSION CRITERIA FOR THIRD-LINE THERAPY: Active severe infection, or known chronic infection with human immunodeficiency virus (HIV) or hepatitis B virus
+Known active hepatitis B infection, active hepatitis C infection or known human immunodeficiency virus (HIV) carrier
+Active hepatitis or human immunodeficiency virus infection
+Patients with human immunodeficiency virus (HIV) infection, or active hepatitis B or C virus infection will be excluded
+PHASE II EXCLUSION CRITERIA: Patients with human immunodeficiency virus (HIV) infection, or active hepatitis B or C virus infection will be excluded
+Active human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C infection.
+Known chronic infection with human immunodeficiency virus (HIV) or viral hepatitis
+Has known human immunodeficiency virus (HIV) and/or Hepatitis B or C infection(s).
+Known infection with Human Immunodeficiency Virus (HIV), and/or active infection with hepatitis B, or hepatitis C.
+Known history of human immunodeficiency virus (HIV), hepatitis B, or hepatitis C infection or known history of tuberculosis
+Have a known human immunodeficiency virus (HIV) infection or known activated/reactivated hepatitis A, B, or C.
+Active human immunodeficiency virus (HIV) or hepatitis B or C infection
+Known human immunodeficiency virus (HIV) or known hepatitis C virus (HCV) infection or active hepatitis B.
+Known Human Immunodeficiency Virus (HIV) infection and/or active Hepatitis B or Hepatitis C infection
+Patients must not have known human immunodeficiency virus (HIV) infection or active hepatitis B or C infections
+Known active human immunodeficiency virus (HIV) or hepatitis B or C infection
+No human immunodeficiency virus (HIV) infection or active hepatitis B or C.
+Known active hepatitis B (HBV) or hepatitis C (HCV) infection or known human immunodeficiency virus (HIV) infection.
+Patients must not have known human immunodeficiency virus (HIV) infection, active hepatitis B and/or hepatitis C.
+Patients with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C
+Known infection caused by human immunodeficiency virus (HIV) or active hepatitis B or C
+Patients with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C
+Patients with a known chronic immunocompromised state, human immunodeficiency virus (HIV) infection, or active hepatitis B or C infection
+Acute hepatitis or known human immunodeficiency virus (HIV)
+CRITERIA FOR SCREENING: Known active hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) infection
+Known to have acute or chronic active hepatitis B infection, hepatitis C infection, or known to have human immunodeficiency virus (HIV) infection
+Known hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection.
+Known human immunodeficiency virus (HIV) or active hepatitis A, B, or C
+History of human immunodeficiency virus (HIV) infection or active hepatitis B or C
+Known human immunodeficiency virus (HIV), active hepatitis A, or hepatitis B or C infection
+Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
+Known active infection with human immunodeficiency virus (HIV), hepatitis B or C viruses (screening not required)
+No human immunodeficiency virus (HIV) infection or active hepatitis B or C
+Patients with known human immunodeficiency virus (HIV) infection or hepatitis
+Known history of human immunodeficiency virus (HIV) or active hepatitis C
+Known active hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) infection
+Known human immunodeficiency virus (HIV) infection or active hepatitis A, B or C
+Has a known history of human immunodeficiency virus (HIV) (HIV/ antibodies), hepatitis B, or hepatitis C infection
+DONOR: Active human immunodeficiency virus (HIV) or hepatitis B or C infection
+Be on immunosuppressive therapy or have human immunodeficiency virus (HIV) infection or active hepatitis B or C
+Patients with known hepatitis B or C or human immunodeficiency virus (HIV) infection
+Known active hepatitis B infection, known history of hepatitis C or human immunodeficiency virus (HIV) infection
+Have a known history of human immunodeficiency virus (HIV) (HIV / antibodies), hepatitis B, or hepatitis C infection
+Active hepatitis B or hepatitis C or known human immunodeficiency virus (HIV) infection
+Known human immunodeficiency virus (HIV) or hepatitis C
+Active and uncontrolled infection including but not limited to known infection with human immunodeficiency virus (HIV), active hepatitis B, or hepatitis C
+Human immunodeficiency virus (HIV) infection, active hepatitis B or C infection, or evidence of liver cirrhosis
+Hepatitis C infection, chronic infection with hepatitis B, infection with human immunodeficiency virus (HIV), or evidence of hepatic insufficiency
+A known history of human immunodeficiency virus (HIV) seropositivity, hepatitis C virus, acute or chronic active hepatitis B infection, or other serious chronic infection requiring ongoing treatment
+Known infection with human immunodeficiency virus (HIV), hepatitis B or C
+Known infection with human immunodeficiency virus (HIV), hepatitis B or C
+History of human immunodeficiency virus (HIV), or known active hepatitis B or C infection.
+No known active or chronic infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C
+Known active infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C.
+Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C.
+Known hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection.
+No infection with human immunodeficiency virus (HIV) and no known history of hepatitis B or hepatitis C virus indicating acute or chronic infection or active tuberculosis (TB)
+Uncontrolled infection with human immunodeficiency virus (HIV) or chronic hepatitis B or C.
+Patients with known active hepatitis B or C or human immunodeficiency virus (HIV) infection or with history of tuberculosis
+Known chronic hepatitis B or C, or human immunodeficiency virus (HIV) infection
+Known active human immunodeficiency virus (HIV) or hepatitis A, B, or C virus infection
+Patients with a known history of human immunodeficiency virus (HIV) infection or active hepatitis B or hepatitis C
+Known active hepatitis B infection, known active hepatitis C infection, or known human immunodeficiency virus (HIV) carrier
+Known human immunodeficiency virus (HIV) infection or known history of active hepatitis B or C infection
+Subjects with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C.
+Has a known Human Immunodeficiency Virus (HIV), or a known, active Hepatitis B (HBV), or a known, active Hepatitis C (HCV) infection.
+Known human immunodeficiency virus (HIV), or Hepatitis B or C.
+Patients with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C
+Known human immunodeficiency virus (HIV) or known active hepatitis B or hepatitis C infection for participants not receiving obinutuzumab pretreatment
+Known Human Immunodeficiency Virus (HIV) infection or active hepatitis A, B, or C
+Known active or chronic hepatitis B or C or human immunodeficiency virus (HIV)
+Known active hepatitis B or C, or human immunodeficiency virus (HIV) infection
+History of human immunodeficiency virus (HIV) infection, active hepatitis B (chronic or acute), or hepatitis C infection
+Known history of human immunodeficiency virus (HIV), or known active hepatitis A, B, or C infection;
+Known human immunodeficiency virus (HIV) infection or chronic hepatitis B
+Active infection with hepatitis B or C or human immunodeficiency virus (HIV)
+Known human immunodeficiency virus (HIV), active hepatitis A, or hepatitis B or C infection
+History of hepatitis B or C, human immunodeficiency virus (HIV), tuberculosis or a chronic infection of any type
+Known human immunodeficiency virus (HIV) infection, active chronic hepatitis B or C, or life-threatening illnesses unrelated to cancer.
+Known active human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C infection on antiviral treatment
+Active infection with hepatitis B or C or human immunodeficiency virus (HIV)
+Known history of human immunodeficiency virus (HIV) and/or active Hepatitis B or C infections
+Known infection with human immunodeficiency virus (HIV), hepatitis B or C
+Known hepatitis B or C virus, or human immunodeficiency virus (HIV) infection
+Known history of human immunodeficiency virus (HIV), active Hepatitis B or C
+Clinically active infection as judged by the treating investigator (? Grade  by CTCAE v) including known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
+Subjects with a known history of hepatitis B or C or human immunodeficiency (HIV) infection.
+Known hepatitis B, hepatitis C or human immunodeficiency virus (HIV) infection
+Subjects with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C.
+Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
+Known human immunodeficiency virus (HIV), hepatitis B and hepatitis C infection
+Known active uncontrolled human immunodeficiency virus (HIV) or hepatitis C infection
+Known human immunodeficiency virus (HIV) or active hepatitis B or C viral infection
+Subjects with known infection with human immunodeficiency virus (HIV) or active hepatitis B or C.
+Known human immunodeficiency virus (HIV) or active hepatitis B or C infection
+Active human immunodeficiency virus (HIV), hepatitis A, B or C infection
+No additional screening intended for human immunodeficiency virus (HIV) or hepatitis infection
+Known chronic infection with human immunodeficiency virus (HIV) or viral hepatitis
+Known human immunodeficiency virus (HIV) infection, hepatitis B or Hepatitis C infection
+No known active or chronic infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C
+No known active or chronic infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C
+Active hepatitis or human immunodeficiency virus (HIV) infection
+Known Human Immunodeficiency Virus (HIV) infection, chronic hepatitis B or C (unless associated with hepatocellular cancer)
+Known Human immunodeficiency virus (HIV) infection or active hepatitis A, B, or C
+Patients with known active viral hepatitis or known human immunodeficiency virus (HIV) infection
+No known human immunodeficiency virus (HIV) infection or chronic hepatitis B or hepatitis C infection
+Known history of Human Immunodeficiency Virus (HIV) infection or chronic hepatitis B or C
+Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C.
+Known active infection with human immunodeficiency virus (HIV), hepatitis B or C
+Known human immunodeficiency virus (HIV) and/or active Hepatitis B or C infections
+Also, known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
+Has known, previously diagnosed human immunodeficiency virus infection or active chronic hepatitis B or C.
+Active hepatitis B infection, active hepatitis C infection or known human immunodeficiency virus (HIV) carrier
+Patients with known human immunodeficiency virus (HIV) or Hepatitis B or C (active, previously treated or both)
+Patients with known human immunodeficiency virus (HIV), or known active hepatitis B or C infections
+Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
+Patients with known human immunodeficiency virus (HIV) or hepatitis B or C
+Known human immunodeficiency virus (HIV) or hepatitis B or C infection
+Patients with active hepatitis B or C infections or a history of human immunodeficiency virus (HIV) infection
+Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C; must test during screening if history is not known
+Previously known infection with human immunodeficiency virus (HIV); or, hepatitis B or C requiring treatment;
+Known and actively treated infection with human immunodeficiency virus (HIV), hepatitis B or C
+Known human immunodeficiency virus (HIV) or active hepatitis B or C infection
+Active severe infection, or known chronic infection with human immunodeficiency virus (HIV) or hepatitis B virus
+Known active human immunodeficiency virus (HIV) infection, hepatitis B or C
+Known infection with human immunodeficiency virus (HIV) or active hepatitis B or C
+Active hepatitis B infection, active hepatitis C infection or known human immunodeficiency virus (HIV) carrier
+Patient with known historical or active infection with human immunodeficiency virus (HIV), hepatitis B or hepatitis C
+Acute hepatitis, known human immunodeficiency virus (HIV), or active uncontrolled infection
+Subjects who are known to have a history of or active human immunodeficiency virus (HIV) or active hepatitis B and/or C
+Have known hepatitis B or C, or human immunodeficiency virus infection
+No infection with human immunodeficiency virus (HIV) and no active infection with hepatitis B and no active or chronic infection with hepatitis C
+Known active hepatitis B, hepatitis C or Human Immunodeficiency Virus (HIV) infection.
+Active Human Immunodeficiency Virus (HIV) or hepatitis B or C infection
+Subjects may not have known human immunodeficiency virus (HIV), active hepatitis A, or hepatitis B or C infection
+Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
+Known or suspected human immunodeficiency virus (HIV) or hepatitis A(acute), B or C infection
+Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
+Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
+Known human immunodeficiency virus (HIV) infection or chronic hepatitis B or C
+Patients with clinically significant infection, including known human immunodeficiency virus (HIV), human herpesvirus- (HHV-), hepatitis C infection, or known hepatitis B surface antigen positivity are not eligible
+Patients with known human immunodeficiency virus (HIV) infection or viral hepatitis
+No known history of human immunodeficiency virus (HIV) or active hepatitis B or C
+Have a known history of human immunodeficiency virus (HIV) (HIV / antibodies), hepatitis B, or hepatitis C infection
+History of known active infection with human immunodeficiency virus (HIV), hepatitis B or hepatitis C
+History of known active infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C
+Known history of or known active infection with human immunodeficiency virus (HIV), hepatitis B or hepatitis C
+Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C
+Known active infection with human immunodeficiency virus (HIV), hepatitis A, B, or C
+Known active hepatitis B/C or HIV (human immunodeficiency virus) infection
+Known history of human immunodeficiency virus (HIV), or active Hepatitis B or C.
+Known human immunodeficiency virus (HIV) seropositive or known hepatitis B or hepatitis C infection.
+Is previously diagnosed human immunodeficiency virus (HIV) infection or active hepatitis B or C.
+Human immunodeficiency virus (HIV), or active hepatitis B or C infection